Abstract
Vascular supply is essential for tumor proliferation and metastasis formation. Correlation was noted between vascular density and tumor size as well as metastases in several tumor types. The aim of the present study was to assess vascular density in nontumorous hypophyses, pituitary adenomas, primary pituitary carcinomas, and carcinomas metastatic to the pituitary.
Twenty nontumorous hypophyses, 87 endocrinologically active or inactive pituitary adenomas, 8 primary pituitary carcinomas, 8 metastatic carcinomas, and 10 randomly selected noninvasive and 6 invasive adenomas were included in the study. Tissues were fixed in formalin, embedded in paraffin, cut, stained with hematoxylin and eosin, PAS, and immunostained for adenohypophysial hormones as well as Factor VIII-related antigen using the streptavidin-biotin-peroxidase complex method Four counts were performed: percentage of capillary area, number of vessels per field, percentage of endothelial cells, and number of endothelial cells per field. The results show that pituitary adenomas have significantly lower vascular densities as compared to nontumorous adenohypophyses. Prolactin-producing adenomas removed from untreated patients have the highest counts and growth hormone-producing adenomas the lowest counts. However, the observed differences among adenoma types are not of statistical significance. No differences are noted between noninvasive and invasive tumors. Primary pituitary carcinomas show no significant increase in vascular densities. Some metastatic tumors exhibit high vascularity. It can be concluded that pituitary adenomas have a limited capacity to induce angiogenesis. Lack of significant angiogenesis may play a role in the slow pace of pituitary tumor growth and rarity of metastases.
Similar content being viewed by others
References
Bosan S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755–761, 1992.
Gasparini G, Weidner N, Bevilacqua P, Maluta S, Palma PD, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinomas. J Clin Oncol 12:454–466, 1994.
Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenal M, Stepniewska K, Harris AL. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastasis and survival in breast cancer. Lancet 340:1120–1124, 1992.
Visscher DW, Smilanetz S, Drozdovicz S, Wykes SM. Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. Anal Quant Cytol Histol 15:88092, 1993.
Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G. Tumor angiogenesis: a new significant and independent prognostic indicator in earlystage breast carcinoma. J Natl Cancer Inst 84:1875–1887, 1992.
Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1–8, 1991.
Gasparini G, Weidner N, Maluta S, Pozza F, Boracchi P, Mezzetti M, Testolin A, Bevilacqua P. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 55:739–744, 1993.
Li VW, Folkerth RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black P.McL, Sallan SE, Folkman J. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344:82–86, 1994.
Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340:145,146, 1992.
Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LF. Prognostic significance of tumor vascularity in intermediate-thickness (0.76–4.0 mm thick) skin melanoma A quantitative histologic study. Am J Pathol 133:419–423, 1988.
Weidner N, Carrol PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401–409, 1993.
Gorczyca W, Hardy J. Arterial supply of the human anterior pituitary gland. Neurosurgery 20:369–378, 1987.
Page RB. Pituitary blood flow. Am J Physiol 243:E427-E442, 1982.
Sheehan HL, Kovacs K. Neurohypophysis and hypothalamus. In: Bloodworth JMB Jr, ed. Endocrine pathology. 2nd ed. Baltimore, MD: Williams and Wilkins, 1982; 45–99.
Stanfield JP. The blood supply of the human pituitary gland. J Anat 94:257–273, 1960.
Xeureb GP, Prichard MML, Daniel PM. The arterial supply and venous drainage of the human hypophysis cerebri. Q J Exp Physiol 39:199–217, 1954.
Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6, 1990.
Folkman J. Angiogenesis and breast cancer. J Clin Oncol 12:141–143, 1994.
Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol 10:302–313, 1993.
Monschke F, Müller WU, Winkler U, Streffer C. Cell proliferation and vascularization in human breast carcinomas. Int J Cancer 49:812–815, 1991.
Horvath E, Kovacs K. The adenohypophysis. In: Kovacs K, Asa SLA, eds. Functional endocrine pathology. Boston, MA: Blackwell, 1991; 245–281.
Horvath E, Kovacs K. Morphology of adenohypophysial cells and pituitary adenomas. In: Imura H, ed. The pituitary gland. 2nd ed. New York, NY: Raven, 1994; 29–62.
Kovacs K, Horvath E. Tumors of the pituitary gland. In: Hartmann WH, ed. Atlas of tumor pathology. 2nd ser. Washington, DC: Fascicle 21, Armed Forces Institute of Pathology, 1986; 1–264.
Kovacs K, Lloyd RV, Horvath E, Asa SL, Stefaneanu L, Killinger DW, Smyth HS. Silent somatotroph adenomas of the human pituitary: a morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization. Am J Pathol 134:345–353, 1989.
Kovacs K, Stefaneanu L, Horvath E, Lloyd RV, Lancranjan I, Buchfelder M, Fahlbusch R. Effects of dopamine agonist medication on prolactin producing pituitary adenomas: a morphologic study including immunocytochemistry, electron microscopy and in situ hybridization. Virchows Arch A Pathol Anat 418:439–446, 1991.
Erroi A, Bassetti M, Spada A, Giannattasio G. Microvasculature of human micro- and macroprolatinomas. A morphological study. Neuroendocrinology 43:159–165, 1986.
Kovacs K, Horvath E. Vascular alterations in adenomas of human pituitary glands. An electron microscopic study. Angiologica 10:299–309, 1973.
Schechter J. Ultrastructural changes in the capillary bed of human pituitary tumors. Am J Pathol 67:107–126, 1972.
Goto F, Goto K, Weindel K, Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69:508–517, 1993.
Hart IR, Saini A. Biology of tumour metastasis. Lancet 339:1453–1457, 1992.
Farnoud MR, Lissak B, Kujas M, Peillon F, Racadot J, Li JY. Specific alterations of the basement membrane and stroma antigens in human pituitary tumours in comparison with the normal anterior pituitary. An immunocytochemical study. Virchows Arch A Pathol Anat 421:449–455, 1992.
Gorczyca W, Hardy J. Microadenomas of the human pituitary and their vascularization. Neurosurgery 22:1–6, 1988.
Schechter J, Goldsmith P, Wilson C, Weiner R. Morphological evidence for the presence of arteries in human prolactinomas. J Clin Endocrinol Metab 67:713–719, 1988.
Weiner RI, Elias KA, Monnet F. The role of vascular changes in the etiology of prolactin secreting anterior pituitary tumors. In: Macleod RM, Thorner MO, Scapagnini U, eds. Prolactin. Basic and clinical correlates, vol. 1. Fidia res ser. Padova, Italy: Liviana Press, 1985; 641–653.
Elias KA, Weiner RI. Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc Natl Acad Sci USA 81:4549–4553, 1984.
Elias KA, Weiner RI. Inhibition of estrogen-induced anterior pituitary enlargement and arteriogenesis by bromocriptine in Fisher 344 rats. Endocrinology 120:617–621, 1987.
Levy A, Lightman SL. The pathogenesis of pituitary adenomas. Clin Endocrinol 38:559–570, 1993.
Alexander JM, Biller BMK, Bikkal H, Zervas NT, Arnold A, Klibanski A. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest 86:336–340, 1990.
Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71:1427–1433, 1990.
Schulte HM, Oldfield EH, Allolio B, Katz BA, Berkman RA, Ali IU. Clonal composition of pituitary adenomas in patients with Cushing’s disease: determination by X-chromosome inactivation analysis. J Clin Endocrinol Metab 73:1302–1308, 1991.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jugenburg, M., Kovacs, K., Stefaneanu, L. et al. Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: A quantitative morphologic study. Endocr Pathol 6, 115–124 (1995). https://doi.org/10.1007/BF02739874
Issue Date:
DOI: https://doi.org/10.1007/BF02739874